Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

Gastroenterology

Volumn 141, Issue 4, 2011, Pages 1194-1201

  Colombel, Jean Frédéric ^a   Rutgeerts, Paul ^b   Reinisch, Walter ^c   Esser, Dirk ^d   Wang, Yanxin ^e   Lang, Yinghua ^f   Marano, Colleen W ^f   Strauss, Richard ^f   Oddens, Björn J ^e   Feagan, Brian G ^g   Hanauer, Stephen B ^h   Lichtenstein, Gary R ⁱ   Present, Daniel ^j   Sands, Bruce E ^j   Sandborn, William J ^k  

^a UNIV LILLE   (France)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d Janssen Biologics   (Netherlands)

^e MERCK RESEARCH LABORATORIES   (United States)

^f CENTOCOR INC   (United States)

^g ROBARTS RESEARCH INSTITUTE   (Canada)

^h UNIVERSITY OF CHICAGO   (United States)

ⁱ UNIVERSITY OF PENNSYLVANIA   (United States)

^j MOUNT SINAI MEDICAL CENTER   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Colectomy; Endoscopic Improvement; Mucosal Healing; Symptomatic Outcomes

Indexed keywords

CORTICOSTEROID; INFLIXIMAB; PLACEBO;

ARTICLE; COLON RESECTION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENDOSCOPY; FOLLOW UP; HEALING; HUMAN; MAJOR CLINICAL STUDY; MUCOSA HEALING; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS;

EID: 80053130407     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.06.054     Document Type: Article

References (21)

1. D.C. Baumgart, and W.J. Sandborn Inflammatory bowel disease: clinical aspects and established and evolving therapies Lancet 369 2007 1641 1657 (Pubitemid 46722637)
2. D.S. Fefferman, and R.J. Farrell Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice Clin Gastroenterol Hepatol 3 2005 11 24 (Pubitemid 40092938)
3. S.B. Hanauer Medical therapy for ulcerative colitis 2004 Gastroenterology 126 2004 1582 1592 (Pubitemid 38649875)
4. S. Lichtiger, D.H. Present, and A. Kornbluth Cyclosporine in severe ulcerative colitis refractory to steroid therapy N Engl J Med 330 1994 1841 1845 (Pubitemid 24188135)
5. P. Rutgeerts, W.J. Sandborn, and B.G. Feagan Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2005 2462 2476 (Pubitemid 41770166)
6. W.J. Sandborn, P. Rutgeerts, and B.G. Feagan Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab Gastroenterology 137 2009 1250 1260
7. S.A. Riley, V. Mani, and M.J. Goodman Microscopic activity in ulcerative colitis: what does it mean? Gut 32 1991 174 178
8. A. Bitton, M.A. Peppercorn, and D.A. Antonioli Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis Gastroenterology 120 2001 13 20 (Pubitemid 32061864)
9. K.F. Frøslie, J. Jahnsen, and B.A. Moum Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort Gastroenterology 133 2007 412 422 (Pubitemid 47187355)
10. I.C. Solberg, I. Lygren, and J. Jøhnsen Mucosal healing after initial treatment may be a prognostic marker for long-term outcome in inflammatory bowel disease Gut 57 Suppl 2 2008 A-15
11. K.W. Schroeder, W.J. Tremaine, and D.M. Ilstrup Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis A randomized study N Engl J Med 317 1987 1625 1629 (Pubitemid 18010466)
12. E. Louis, A. Collard, and A.F. Oger Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease Gut 49 2001 777 782 (Pubitemid 33096034)
13. H.J. Freeman Natural history and clinical behavior of Crohn's disease extending beyond two decades J Clin Gastroenterol 37 2003 216 219 (Pubitemid 37010915)
14. J. Cosnes, S. Cattan, and A. Blain Long-term evolution of disease behavior of Crohn's disease Inflamm Bowel Dis 8 2002 244 250 (Pubitemid 34784976)
15. M.H. Vatn Mucosal healing: impact on the natural course or therapeutic strategies Dig Dis 27 2009 470 475
16. P. Rutgeerts, R.H. Diamond, and M. Bala Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease Gastrointest Endosc 63 2006 433 442 (Pubitemid 43261469)
17. M. Ferrante, S. Vermeire, and H. Fidder Long-term outcome after infliximab for refractory ulcerative colitis J Crohns Colitis 2 2008 219 225
18. M.D. Rutter, B.P. Saunders, and K.H. Wilkinson Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk Gut 53 2004 1813 1816 (Pubitemid 39556902)
19. M. Rutter, B. Saunders, and K. Wilkinson Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis Gastroenterology 126 2004 451 459 (Pubitemid 38182302)
20. S.H. Itzkowitz, and X. Yio Inflammation and cancer IV Colorectal cancer in inflammatory bowel disease: the role of inflammation Am J Physiol Gastrointest Liver Physiol 287 2004 G7 G17
21. J.D. Lewis, S. Chuai, and L. Nessel Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis Inflamm Bowel Dis 14 2008 1660 1666